The dynamics of telomere attrition in human beings might shape the course of age-dependent, complex genetic traits. One of these traits is essential hypertension. Age-dependent telomere attrition could lead to critically shortened telomeres and aneuploidy (ie, the loss or gain of chromosomes) with a resultant mosaicism that will be variably expressed in different cells and tissues. C omplex genetic traits are common maladies that cause high morbidity and mortality rates in a large segment of the adult population. These genetic traits include disorders whose prevalence increase with aging, including essential hypertension, non-insulin-dependent diabetes mellitus, and atherosclerosis. To understand these disorders it is necessary to chart their pathogenesis as a function of age, which in biologic terms involves growth, development, and senescence. In this review we use essential hypertension, which afflicts roughly 25% of the adult population in the USA, 1 to illustrate these concepts. However, similar considerations are applicable to other common age-dependent complex genetic traits.
C omplex genetic traits are common maladies that cause high morbidity and mortality rates in a large segment of the adult population. These genetic traits include disorders whose prevalence increase with aging, including essential hypertension, non-insulin-dependent diabetes mellitus, and atherosclerosis. To understand these disorders it is necessary to chart their pathogenesis as a function of age, which in biologic terms involves growth, development, and senescence. In this review we use essential hypertension, which afflicts roughly 25% of the adult population in the USA, 1 to illustrate these concepts. However, similar considerations are applicable to other common age-dependent complex genetic traits.
The effects of the environment on blood pressure are powerful and omnipresent and in industrialized societies essential hypertension reflects genetic-environmental interactions. In addition, aging is perhaps the most important element in the development and progression of essential hypertension. However, under similar environmental conditions, the manifestation of essential hypertension in the fourth decade of life, as opposed to the seventh decade of life, for example, is suggestive of the earlier expression of hypertension susceptibility genes. What then are the biologic clocks that control the temporal expression of the genes that cause essential hypertension? What are the underlying mechanisms of these clocks? Do these clocks keep time differently in individuals prone to essential hypertension? How are these clocks modified by hypertension or the environment? Such questions are yet to be satisfactorily answered as the search for the genes that contribute to susceptibility to essential hypertension continues.
Families of biologic clocks regulate circadian and seasonal rhythmicity. 2 However, recent evidence suggests that another biologic clock, the telomere, might pace the cellular life span in vitro and perhaps in vivo. We 3 previously proposed that "the telomere hypothesis of cellular aging," originally introduced by Harley 4 and Greider 5 , might explain the enigmatic expressions of essential hypertension, including the age-dependency of the disorder and its unstable phe-notypic expressions. Here we review the evidence that telomeres play a role in an age-dependent increase in the frequency of aneuploidy, genomic instability, and loss of heterozygosity, and suggest that such processes could be involved in the pathogenesis of essential hypertension and its cardiovascular complications.
TELOMERE ATTRITION AND AGING
The essence of the "telomere hypothesis of cellular aging" is that, because of the "end replication problem," 6, 7 telomeres undergo progressive attrition (shortening) with each replicative cycle of the cell. In proliferating somatic cells, the mean length of telomeres is an indicator of not only replicative history, but also replicative potential. This results from the fact that, at least in vitro, human cells exit from the cell cycle and become senescent when the mean length of their telomeres decreases to a critical value (ϳ4 to 6 kilobases [kb]). It is noteworthy, however, that the length of telomeres varies widely among chromosomes. 8, 9 Thus, telomere length, critically shortened in one chromosome, could have an impact on cell function even before more widespread or total loss of replicative capacity.
A vast body of data suggests that the principles of "the telomere hypothesis of cellular aging" are valid not only for cultured cells but also in vivo, as the telomere length of cells with replicative potential (eg, vascular endothelial cells, epithelial cells, skin fibroblasts, and white blood cells) is inversely related to the donor's age. 10 -14 This is particularly relevant for human beings, because their telomere length is much shorter than that of the mouse strains that have been extensively used in telomere research. [15] [16] [17] [18] Therefore, telomere attrition might play a more prominent role in the biology of aging in humans than in the mouse, because in principle, telomere length could become critically shortened in proliferative tissues within the much longer life span of humans. 19 In addition, telomere length is synchronized among organs of the human fetus, 20 perhaps because of the substantial activity in fetal organs of telomerase, 21, 22 the enzyme that counteracts telomere attrition. 23, 24 However, other mechanisms that regulate telomere length could also differ during intrauterine versus extrauterine life.
For instance, nontelomerase, telomere-binding proteins appear to regulate telomere length. 25, 26 It is noteworthy that telomerase is active not only in fetal tissues, but also in most neoplasms and in virally transformed, immortal cell lines. 23, 27, 28 In this way abnormal cellular proliferation can proceed unrestricted. A recent work 24 has elegantly demonstrated that transfecting cultured somatic cells with no apparent telomerase activity with a vector encoding the human telomerase catalytic subunit induces an unabated and apparently normal cellular proliferation without evidence of telomere attrition or cellular senescence. These observations, plus the fact that the length of telomeres is heritable, 9, 12 indicate that the telomere clock is genetically preset in somatic cells and that it might register a different biologic time in various tissues and organs. In this context, biologic clocks in postmitotic cells, eg, nerve cells, operate via mechanisms that are likely to be independent of telomere attrition.
Based on the premise that the length of telomeres is inherited and evidence that in replicating somatic cells telomeres become shorter as a function of age, we proposed the following potential role of telomeres in the development and clinical manifestation of essential hypertension 3 : individuals who inherit shorter telomeres are more likely to show at a relatively younger age dysfunctions related to telomere attrition, including the expression of variant genes that cause high blood pressure. Alternatively or simultaneously, essential hypertension enhances the turnover rates of specific cell types. This then increases the attrition rate in telomere length and promotes the premature expression of genes that cause the aging of these cells. Such a phenomenon, therefore, occurs first in individuals who inherit short telomeres. Whether primary or secondary, telomere attrition can thus shape the clinical course of essential hypertension by either raising blood pressure or accelerating the hypertension-mediated aging of tissues that are involved in the pathogenesis of this disorder. The distinction between cellular aging and systemic aging is crucial in this context, because these processes are not interchangeable.
From the biologic standpoint, depending on genetic and environmental circumstances, a given tissue or physiologic system within the organism can be older than the organism as a whole. For instance, endothelial cells of the human vasculature, like other replicating cells, exhibit an age-dependent reduction in telomere length. 10 Interestingly, the telomere length is shorter in the vascular endothelial cells of the iliac artery than in the internal thoracic artery, regardless of the donor's age. This phenomenon might relate to an increase in the turnover rate of vascular endothelial cells in the iliac artery, perhaps because of the high hemodynamic stress in this vascular segment. Essential hypertension, which causes an increase in the hemodynamic stress, might accelerate the aging of large segments of the vascular tree. It is noteworthy, nonetheless, that environmentally or genetically induced diseases that are associated with short telomere length do not present only in older subjects. For instance, shortened telomere length has been observed in the white blood cells of patients with insulin-dependent diabetes mellitus 29 or in subjects with HIV disease. 30, 31 Whether telomere length and attrition are primarily or secondarily involved in these disorders is not clear at present.
TELOMERE ATTRITION AND ANEUPLOIDY
Although telomere research has provided important clues about the mechanisms that control telomere length, 32, 33 little is known about the specific processes by which telomere attrition modifies gene expression and cell function. The common concept is that telomeres protect the gene-rich subtelomeric regions and play a role in cell replication, 34 -36 yet there is meager information about how these functions are carried out. It has been proposed that telomere attrition mediates cellular senescence by altering the expression, including release from silencing, of senescence genes in subtelomeric regions. However, such a mechanism has not been established for mammalian cells. 37 Thus, other mechanisms attributed to telomere attrition must be considered in any attempts to explain the altered gene expression as human beings age. Two relevant and related issues that are the focus of this review are: 1) whether critically shortened telomeres can cause alterations in chromosomal number (ie, aneuploidy) and 2) whether aneuploidy occurs in vivo as a function of human aging.
Could aneuploidy be an ultimate consequence of telomere attrition? Based on recent developments, the answer to this question is clearly in the affirmative. Studies in the telomerase knockout mouse 17, 38 and in cultured mouse cells lacking the telomerase RNA component 39 showed that critically shortened telomeres promote an increased frequency of aneuploidy. In addition, although telomere attrition does not appear to cause senescence in yeast, telomere truncation in yeast strains results in chromosomal instability and the loss of the respective chromosome. 40 It is noteworthy that under certain circumstances both the loss or gain of chromosomes might represent a related phenomenon of telomere attrition, 38 as chromosomal instability, evoked by the loss of a telomere, might include mitotic aberrations, such as nondysjunction (the failure of proper chromosomal separation during anaphase) as well as yet poorly understood mechanisms.
Could aneuploidy occur in apparently normal human beings? In an attempt to answer this question, previous studies have focused on circulating lymphocytes because of their easy availability and their capacity to divide in vitro in response to mitogens, thereby providing metaphase cells for cytogenic evaluations. Metaphase analyses of these cells as well as bone marrow cells have shown that the frequency of aneuploidy for one or more chromosomes usually increases with the donor's age. This is primarily expressed by the loss of the X or occasionally the Y chromosomes. [41] [42] [43] [44] Metaphase analyses of nonhematopoietic cells (ie, stromal keratocytes of the human cornea and skin fibroblasts) have confirmed the loss of sex chromosomes as a function of age, but they also showed that aneuploidy of autosomes was quite common in these cells. 45, 46 It is noteworthy, however, that evaluating metaphase chromosomes leaves aneuploidy in interphase cells undetected if aneuploid cells are selected against when beginning mitosis. 47, 48 Indirect evidence supports this concept at least in the context of telomere attrition, because a critical length of individual telomeres is apparently needed for hematopoietic cells to enter metaphase in vivo. 8 The recent developments of chromosome-specific probes have provided the tools to enumerate chromosomes in nondividing cells by fluorescent in situ hybridization (FISH) and to explore age-dependent aneuploidy in interphase cells. Studies using FISH technology have confirmed age-dependency of the frequencies of X and Y chromosomal hypoploidy in interphase nuclei from skin fibroblasts 46 and peripheral lymphocytes. 48 Moreover, the frequencies of aneuploidy of autosomes in interphase nuclei of skin fibroblasts were found to be strongly correlated with the donor's age. 46 The study in skin fibroblasts is of particular relevance in that it is a longitudinal investigation of age-dependent aneuploidy in human beings. 46 
TELOMERE ATTRITION AND LOSS OF HETEROZYGOSITY DUE TO AGE-DEPENDENT ANEUPLOIDY: IMPLICATIONS IN ESSENTIAL HYPERTENSION
In light of these new developments, it is reasonable to conclude that telomere attrition ultimately promotes age-dependent aneuploidy. The frequency of aneuploidy in a given cell type would be a function of the inherited length of telomeres, the rate of telomere attrition resulting from cellular turnover rate, and time. One important characteristic of aging might therefore be the development of mosaicism because of the loss or gain of chromosomes. Such mosaicism will be hidden (ie, undetected by standard cytogenetic methodology involving metaphase cell analysis) because it occurs only in subsets of interphase cells within various organs. Over time, the cumulative impact of this mosaicism will be genomic instability and progressive loss of heterozygosity in cells that manifest a high degree of age-dependent aneuploidy. This would result in the augmented expression of variant genes that contribute to complex genetic traits.
The following is a hypothetical scenario that illustrates the concept in the context of hypertension in human beings. Liddle's syndrome is an autosomal dominant form of monogenic hypertension resulting from mutation in the genes encoding the ␤-and ␥-subunits of the amiloride-sensitive Na ϩ channel. 49, 50 Both genes are located on chromosome 16. The abnormal Na ϩ channels that arise from these mutations substan-tially increase Na ϩ reabsorption in the collecting tubules of the kidneys, resulting in a salt sensitive form of hypertension that is usually apparent at a young age. However, mutations that cause Liddle's syndrome are extremely rare in the general population and, therefore, they are unlikely to play a role in essential hypertension, which is a very common disorder in adults.
Recent investigations have identified more common variants of the gene that encodes the ␤-subunit of the amiloride-sensitive Na ϩ channel. [51] [52] [53] [54] These variants were almost exclusively identified in individuals of recent African ancestry. The frequency of one variant, T594M, was similar in hypertensive black Americans (5.6%) and in normotensive black Americans (6.7%), 51 whereas it was higher in hypertensive blacks (8.3%) than in normotensive blacks (2.1%) in London. 52 Another variant, G589S, showed a higher activity than the wild type when expressed in Xenopus oocytes, but did not show cosegregation with hypertension. 54 At present, there is simply insufficient evidence that even one of these variant genes plays a role in essential hypertension in blacks. It is noteworthy, nonetheless, that salt sensitivity and the salt sensitive form of essential hypertension are common in individuals of African ancestry and that salt sensitivity increases with age. 55 Moreover, it is also clear that increased activity of the amiloride-sensitive Na ϩ channel can cause a salt sensitive form of essential hypertension. Thus, it is possible that if one or more common variants of the ␤-subunits of the amiloride-sensitive Na ϩ channel causes salt sensitivity, individuals who are heterozygous for such a variant might show neither salt sensitivity nor hypertension at a young age. However, cellular turnover of the renal tubular epithelium could result in an age-dependent increase in the frequency of cells aneuploid for chromosome 16 . This would augment the impact of the variant genes of the ␤-subunit of the amiloride-sensitive Na ϩ channel via a number of processes, including the loss of heterozygosity. Thus, salt sensitivity in some individuals of African origin who are heterozygous for the variant genes would increase with age, thereby playing a greater role in blood pressure elevation as these individuals got older. Such a concept fits well with the genetic theory of antagonistic pleiotrophy that suggests that a trade-off exists between early benefits and late costs of certain genes. 56 The early benefit of the variant genes of the amiloride-sensitive Na ϩ channel might be Na ϩ retention under conditions of salt deprivation, whereas the late cost (in modern societies) could be hypertension.
CONCLUSIONS
A model for essential hypertension must account for the age-dependent rise in the frequency and severity of blood pressure elevation. Because essential hypertension is a genetic disorder, it is reasonable to assume that persons with essential hypertension carry variant genes that elevate blood pressure. The interactive paradigm for essential hypertension proposed herein incorporates age dependency by ascribing roles to the genetic endowment of telomere length, the rate of telomere attrition, and one penultimate consequence of telomere attrition, ie, aneuploidy. According to this dynamic model, the characteristics of blood pressure and hypertension will keep changing as different (variant and normal) genes are over-and underexpressed in different organs with the passage of time. Moreover, because loss of a pair of chromosomes is incompatible with survival of the cell, the loss of heterozygosity and other genomic abnormalities that result from age-dependent telomere attrition should manifest stochastic features that depend on whether alleles carrying normal genes or alleles carrying variant genes are lost first. Every cell that loses (or gains) a chromosome because of telomere attrition would then have an even chance of augmenting or diminishing the expression of variant genes on that chromosome. Yet, in the aggregate, the stochastic effect would increase with age. Such a phenomenon adds another degree of complexity to studying the genetics of essential hypertension, particularly in older people.
The course of essential hypertension might then depend on not only the specific nature of susceptibility genes for blood pressure elevation, but also on the rate of telomere attrition in specific chromosomes as a function of age. Such a concept contrasts with reductionist formulations that ascribe fixed proportions to the contributions that variant genes may make to the development of essential hypertension. According to this dynamic model, essential hypertension cannot be broken down or reduced to its separate, interactive elements. Thus, the genetic etiology of essential hypertension is likely to elude investigations that use standard genetic approaches that do not account for the impact of time and that rely on stable intermediate phenotypes for genetic linkage and association analyses.
